Cost-effectiveness of pan-genotypic direct-acting antiviral regimens for treatment of chronic Hepatitis C in the United States
Author:
Affiliation:
1. Division of Gastroenterology, Henry Ford Hospital, Detroit, MI, USA
2. Gilead Sciences, Inc., Foster City, CA, USA
3. Maple Health Group, LLC, New York, NY, USA
4. Icahn School of Medicine at the Mount Sinai School of Medicine, New York, NY, USA
Funder
Gilead Sciences
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Health Policy,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737167.2019.1629291
Reference42 articles.
1. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016
2. Chronic hepatitis C virus (HCV) disease burden and cost in the United States
3. Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals
4. Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6
5. Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019;Value in Health;2024-08
2. Cost effectiveness of hepatitis C direct acting agents;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-03
3. Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies;PharmacoEconomics - Open;2024-01-03
4. Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California;The American Journal of Managed Care;2023-10-20
5. Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective;Journal of Managed Care & Specialty Pharmacy;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3